Comparative bioavailability study of capecitabine tablets of 500 mg in metastatic breast cancer and colorectal cancer patients under fed condition C Gadiko, SK Tippabhotla, S Thota, R Battula, M Nakkawar, S Yergude, ... Clinical Research and Regulatory Affairs 29 (3-4), 72-76, 2012 | 7 | 2012 |
Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers C Gadiko, SK Tippabhotla, S Thota, M Nakkawar, R Cheerla, MR Betha, ... Journal of Drug Assessment 2 (1), 21-29, 2013 | 6 | 2013 |
Pharmacokinetics of two formulations of alendronate sodium/cholecalciferol (vitamin D3) tablets 70 mg/5600 IU: An open-label, randomized, single-dose, two … SK Tippabhotla, S Thota, SM Khan, C Gadiko, S Yergude, R Cheerla, ... Clinical research and regulatory affairs 30 (1-2), 14-22, 2013 | 5 | 2013 |
Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: A randomized, open-label, single-dose, two-way crossover study in healthy human subjects SK Tippabhotla, MR Betha, C Gadiko, R Battula, M Nakkawar, R Cheerla, ... Drug research 63 (05), 250-257, 2013 | 4 | 2013 |
Single dose pharmacokinetics and bioequivalence of conjugated estrogens (0.625 mg× 2) tablets in healthy post-menopausal female subjects in fasting and fed studies SK Tippabhotla, M Nakkawar, C Gadiko, MR Betha, SM Khan, S Yergude, ... Clinical Research and Regulatory Affairs 30 (1-2), 23-30, 2013 | | 2013 |
Steady-state pharmacokinetics and bioequivalence study of quetiapine fumarate film-coated tablets 300 mg in adult schizophrenic patients MR Betha, SK Tippabhotla, S Yergude, SM Khan, M Nakkawar, C Gadiko, ... Clinical Research and Regulatory Affairs 29 (3-4), 65-71, 2012 | | 2012 |